Carrie Brownstein Zentalis Pharmaceuticals, Inc. (ZNTL) insider trading activity

ZNTL Quotes by TradingView

Carrie Brownstein is Chief Medical Officer of Zentalis Pharmaceuticals, Inc.. Currently has a direct ownership of 105,685 shares of ZNTL, which is worth approximately $341,362. The most recent transaction as insider was on Oct 04, 2023, when has been sold 10,628 shares (Common Stock) at a price of $19.67 per share, resulting in proceeds of $209,052. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 106K
0% 3M change
9.14% 12M change
Total Value Held $341,362

Carrie Brownstein Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 04 2023
SELL
Open market or private sale
$209,052 $19.67 p/Share
10,628 Reduced 9.14%
105,685 Common Stock
Feb 01 2023
BUY
Grant, award, or other acquisition
-
16,313 Added 12.3%
116,313 Common Stock
Oct 03 2022
BUY
Grant, award, or other acquisition
-
100,000 Added 50.0%
100,000 Common Stock

Also insider at

STTK
Shattuck Labs, Inc. Healthcare
CB

Carrie Brownstein

Chief Medical Officer
Austin, TX

Track Institutional and Insider Activities on ZNTL

Follow Zentalis Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ZNTL shares.

Notify only if

Insider Trading

Get notified when an Zentalis Pharmaceuticals, Inc. insider buys or sells ZNTL shares.

Notify only if

News

Receive news related to Zentalis Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ZNTL